Determining the reliability of liver biopsies in NASH clinical studies
Crossref DOI link: https://doi.org/10.1038/s41575-020-00363-8
Published Online: 2020-09-04
Published Print: 2020-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Longerich, Thomas
Schirmacher, Peter
Text and Data Mining valid from 2020-09-04
Version of Record valid from 2020-09-04
Article History
First Online: 4 September 2020
Competing interests
: P.S. and T.L. are involved in centralized liver biopsy evaluation in clinical studies (Dr. Falk Pharma GmbH).